Levothyroxine Sodium impurity
|
|
|
- CAS-Nr.
- 27566-09-2
- Englisch Name:
- Levothyroxine Sodium impurity
- Synonyma:
- Salbutamol Impurity 47;Salbutamol Impurity 72;Salbutamol Impurity 114;Venadaparib Impurity 52;Salbutamol Impurity 121;Salbutamol EP Impurity 40;Salbutamol Impurity IIa-6;Levothyroxine Sodium IMP;Levothyroxine Sodium impurity;Levothyroxine sodium intermediate
- CBNumber:
- CB23144684
- Summenformel:
- C14H21NO4
- Molgewicht:
- 267.32
- MOL-Datei:
- 27566-09-2.mol
|
Levothyroxine Sodium impurity Eigenschaften
- Siedepunkt:
- 416.7±45.0 °C(Predicted)
- Dichte
- 1.153±0.06 g/cm3(Predicted)
- pka
- 9.60±0.31(Predicted)
Sicherheit
Levothyroxine Sodium impurity Chemische Eigenschaften,Einsatz,Produktion Methoden
Levothyroxine Sodium impurity Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Levothyroxine Sodium impurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 20)Lieferanten
- Levothyroxine Sodium impurity
- Levothyroxine Sodium IMP
- Levothyroxine sodium intermediate
- methyl 3-bromo-5-(2,2-dihydroxyacetyl)-2-hydroxybenzoate
- methyl 5-acetyl-3-bromo-2-hydroxybenzoate
- 2-(4-(2-(4-hydroxy-3-(methoxycarbonyl)phenyl)-2-oxoacetoxy)-3-(methoxycarbonyl)phenyl)-2-oxoacetic acid
- methyl 5-(2-(tert-butylamino)-1-hydroxyethyl)-2-hydroxybenzoate
- 5-(2-(tert-butylamino)-1-hydroxyethyl)-2-hydroxybenzoic acid
- methyl 5-(tert-butylglycyl)-2-hydroxybenzoate
- ethyl (R)-2-acetamido-3-(4-hydroxy-3,5-diiodophenyl)propanoate
- Benzoic acid, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-hydroxy-, methyl ester
- Salbutamol Impurity 114
- Salbutamol Impurity 47
- Salbutamol EP Impurity 40
- 4-(2-bromoacetyl)-3-hydroxybenzaldehyde
- Salbutamol Impurity 72
- Venadaparib Impurity 52
- Salbutamol Impurity IIa-6
- Salbutamol Impurity 121
- 27566-09-2
